Lido Advisors’s Medpace MEDP Stock Holding History

Lido Advisors’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$644K	Buy	1,031 +121	+13%	+$70.9K	﹤0.01%	1330
2026 Q2	$482K	Buy	+910	New	+$420K	﹤0.01%	1499
2026 Q1	–	Sell	-393	Closed	-$211K	–	2059
2025 Q4	$211K	Buy	+393	New	+$223K	﹤0.01%	1744

Other funds holding MEDP

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $234B AUM 43.58% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $13.5B AUM 16.58% 1-Year Est. Return

Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $106B AUM 2.29% 1-Year Est. Return

Lido Advisors's MEDP Position: Q3 2026 in Review

Lido Advisors increased its Medpace (MEDP) stake by 13% in Q3 2026, buying an estimated $70.9K and bringing the position to 1,031 shares worth $644K. The position accounts for ﹤0.01% of the portfolio, ranked #1330.

Lido Advisors first reported a position in MEDP in Q4 2025 and has held it in 3 quarters since. 619 funds tracked by Wall St. Rank hold MEDP as of Q3 2026.

Lido Advisors held 1,031 shares of Medpace worth $644K as of Q3 2026.
Lido Advisors bought 121 Medpace shares in Q3 2026, an estimated $70.9K.
Medpace made up ﹤0.01% of Lido Advisors's portfolio in Q3 2026, its #1330 holding.
Lido Advisors first reported a position in Medpace in Q4 2025 and has held it in 3 quarters since.
619 funds tracked by Wall St. Rank held Medpace as of Q3 2026.

Based on Lido Advisors's 13F filing for Q3 2026, filed 4 Nov 2026.